文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

免疫功能受损脓毒症患者炎症亚型的预后相关性

Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With Sepsis.
PubMed 文献 · Crit Care Med · 2025-10-28
一句话结论在脓毒症患者中,血液系统恶性肿瘤与高炎症亚型强相关(OR 4.3),且高炎症亚型与血液系统恶性肿瘤患者生存率降低相关,但在实体器官移植或实体恶性肿瘤患者中无此关联。

该观察性队列研究纳入美国两个ICU队列共1826例脓毒症患者,采用潜类别分析预先划分高炎症与低炎症亚型,免疫功能受损定义为实体器官移植史、AIDS、血液系统恶性肿瘤、接受化疗的实体恶性肿瘤或免疫抑制药物使用。结果显示血液系统恶性肿瘤与高炎症亚型强相关(OR 4.3,p<0.0001),调整病原体、菌血症或疾病严重程度后仍持续;实体器官移植史亦相关(OR 1.6,p=0.02),但校正菌血症后不再显著。高炎症分类与血液系统恶性肿瘤患者生存率降低相关,但在器官移植或实体恶性肿瘤人群中无此关联。结论认为预先存在的免疫状态与亚型分配相关,并可能影响其预后效用。

要点

  • 在1826例脓毒症患者中,血液系统恶性肿瘤与高炎症亚型强相关(OR 4.3,p<0.0001),调整病原体、菌血症或疾病严重程度后仍持续。
  • 实体器官移植史与高炎症亚型相关(OR 1.6,p=0.02),但校正菌血症后不再显著。
  • 高炎症分类与血液系统恶性肿瘤患者生存率降低相关,但在器官移植或实体恶性肿瘤人群中无此关联。
  • 预先存在的免疫状态与亚型分配相关,并可能影响其预后效用。

适用人群与场景

  • 美国两个ICU队列的脓毒症患者,共1826例。
  • 免疫功能受损定义为实体器官移植史、AIDS、血液系统恶性肿瘤、接受化疗的实体恶性肿瘤或免疫抑制药物使用。

诊断标准与关键阈值

  • 亚型通过潜类别分析预先分配。
  • 免疫功能受损定义包括:实体器官移植史、AIDS、血液系统恶性肿瘤、接受化疗的实体恶性肿瘤或免疫抑制药物使用。

研究设计与关键结果

  • 研究类型:观察性队列研究,纳入美国两个ICU队列共1826例脓毒症患者。
  • 血液系统恶性肿瘤与高炎症亚型强相关(OR 4.3,p<0.0001),调整病原体、菌血症或疾病严重程度后仍持续。
  • 实体器官移植史与高炎症亚型相关(OR 1.6,p=0.02),但校正菌血症后不再显著。
  • 高炎症分类与血液系统恶性肿瘤患者生存率降低相关,但在器官移植或实体恶性肿瘤人群中无此关联。

证据类型、等级与局限

  • 证据类型:观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在脓毒症患者中,血液系统恶性肿瘤病史与高炎症亚型强相关(OR 4.3),提示对该人群进行亚型分类可能有助于预后判断。
  • 高炎症亚型与血液系统恶性肿瘤患者生存率降低相关,但在实体器官移植或实体恶性肿瘤患者中无此关联,亚型的预后效用可能因免疫受损类型而异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Hyperinflammatory and hypoinflammatory molecular subphenotypes in sepsis and acute respiratory distress syndrome have divergent mortality and treatment responses in secondary analyses of randomized controlled trials. However, the prevalence of immunocompromise is low in these populations, and how preexisting immunocompromise contributes to subphenotypes is unknown. We studied two observational sepsis cohorts to test associations between immunocompromise and the hyperinflammatory subphenotype and to assess whether the prognostic relevance of molecular subphenotypes is generalizable to immunocompromised populations.

DESIGN: Observational cohort study.

SETTING: Prospective data from two ICU cohorts in the United States.

PATIENTS: We included 1826 patients from two combined sepsis cohorts.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We defined immunocompromise as a history of solid organ transplant, AIDS, hematologic malignancy, solid malignancy on chemotherapy, or immunosuppressive medication use. Subphenotype was previously assigned using latent class analysis. We used logistic regression to investigate associations between type of immunocompromise and hyperinflammatory subphenotype. Models were repeated with individual covariates known or hypothesized to be associated with the hyperinflammatory subphenotype. Kaplan-Meier survival plots were used to assess mortality differences by subphenotype. Hematologic malignancy was strongly associated with the hyperinflammatory subphenotype (odds ratio [OR], 4.3; p < 0.0001), an association that persisted after adjustment for identified pathogen, presence of bacteremia, or illness severity. History of solid organ transplantation was also associated with the hyperinflammatory subphenotype (OR, 1.6; p = 0.02) but was no longer significant after accounting for bacteremia. Hyperinflammatory classification was associated with a decreased likelihood of survival in hematologic malignancy, but not in organ transplant or solid malignancy populations.

CONCLUSIONS: Preexisting immune status is associated with subphenotype assignment and may influence its prognostic utility.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Weingart MF, Willmore A, Zhuo H, et al. Prognostic Relevance of Inflammatory Subphenotypes in Immunocompromised Patients With Sepsis. Crit Care Med. 2025. PMID: 41150892. doi:10.1097/CCM.0000000000006920

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。